RYZOLT Drug Patent Profile
✉ Email this page to a colleague
When do Ryzolt patents expire, and what generic alternatives are available?
Ryzolt is a drug marketed by Purdue Pharma and is included in one NDA.
The generic ingredient in RYZOLT is tramadol hydrochloride. There are thirty-six drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the tramadol hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ryzolt
A generic version of RYZOLT was approved as tramadol hydrochloride by SUN PHARM INDS INC on June 19th, 2002.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for RYZOLT?
- What are the global sales for RYZOLT?
- What is Average Wholesale Price for RYZOLT?
Summary for RYZOLT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 142 |
Clinical Trials: | 1 |
Patent Applications: | 2,506 |
What excipients (inactive ingredients) are in RYZOLT? | RYZOLT excipients list |
DailyMed Link: | RYZOLT at DailyMed |
Recent Clinical Trials for RYZOLT
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Medical College of Wisconsin | Phase 2 |
Paragraph IV (Patent) Challenges for RYZOLT
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
RYZOLT | Extended-release Tablets | tramadol hydrochloride | 100 mg, 200 mg and 300 mg | 021745 | 1 | 2009-06-18 |
US Patents and Regulatory Information for RYZOLT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Purdue Pharma | RYZOLT | tramadol hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021745-001 | Dec 30, 2008 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Purdue Pharma | RYZOLT | tramadol hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021745-002 | Dec 30, 2008 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Purdue Pharma | RYZOLT | tramadol hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021745-003 | Dec 30, 2008 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for RYZOLT
International Patents for RYZOLT
See the table below for patents covering RYZOLT around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
South Africa | 9201366 | ⤷ Sign Up | |
South Africa | 9409296 | ⤷ Sign Up | |
Indonesia | 25988 | ⤷ Sign Up | |
Norway | 924597 | ⤷ Sign Up | |
India | 173298 | Method for obtaining a stabilized controlled release formulation | ⤷ Sign Up |
Australia | 682223 | ⤷ Sign Up | |
Spain | 2088312 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for RYZOLT
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0566709 | C300152 | Netherlands | ⤷ Sign Up | PRODUCT NAME: TRAMADOLI HYDROCHLORIDUM EN PARACETAMOLUM; NAT. REGISTRATION NO/DATE: RVG 28113 20030115; FIRST REGISTRATION: 359 228-3 2002050405 |
0566709 | SPC/GB04/012 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: TRAMADOL HYDROCHLORIDE, PARACETAMOL; REGISTERED: FR NL 25970 20020405; UK PL 00242/0384 20030925 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |